Perkenalan

Halaman ini memberikan analisis komprehensif tentang riwayat insider trading yang diketahui di Gary L Crocker. Insider adalah pejabat, direktur, atau investor penting dalam suatu perusahaan. Adalah ilegal bagi insider untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik dan non-publik. Hal ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan ke SEC melalui Formulir 4. Meskipun ada pembatasan ini, penelitian akademis menunjukkan bahwa insider – secara umum – cenderung mengungguli pasar di perusahaan mereka sendiri.

Profitabilitas Perdagangan Rata-rata

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari seluruh pembelian pasar terbuka yang dilakukan oleh insider dalam 3 tahun terakhir. Untuk menghitungnya, kami memeriksa setiap pembelian pasar terbuka dan tidak terencana yang dilakukan oleh insider, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata perdagangan tersebut selama 3, 6, dan 12 bulan, merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami menghitung rata-rata semua metrik kinerja untuk menghitung metrik kinerja bagi insider. Daftar ini hanya mencakup insider yang telah melakukan setidaknya tiga perdagangan dalam 2 tahun terakhir.

Jika profitabilitas perdagangan insider ini adalah "T/A", maka insider tersebut belum melakukan pembelian di pasar terbuka dalam 3 tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang dapat diandalkan.

Frekuensi Pembaruan: Harian

Lihat daftar insider trader yang paling menguntungkan.

Perusahaan dengan Posisi Insider yang Dilaporkan

Pengajuan SEC menunjukkan Gary L Crocker telah melaporkan kepemilikan atau perdagangan di perusahaan berikut:

Keamanan Judul Kepemilikan Terbaru yang Dilaporkan
US:MACK / Merrimack Pharmaceuticals, Inc. See Remarks, Director 133.105
Bagaimana Menafsirkan Grafik

Bagan berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka dan tidak terencana yang dilakukan oleh Gary L Crocker. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham dipetakan sebagai persentase perubahan kumulatif harga saham. Misalnya, jika perdagangan insider dilakukan pada tanggal 1 Januari 2019, grafik akan menunjukkan persentase perubahan harian sekuritas hingga hari ini. Jika harga saham naik dari $10 menjadi $15 selama waktu ini, persentase perubahan harga saham kumulatif akan menjadi 50%. Perubahan harga dari $10 menjadi $20 adalah 100%, dan perubahan harga dari $10 menjadi $5 adalah -50%.

Pada akhirnya, kami mencoba untuk menentukan seberapa dekat korelasi perdagangan insider dengan keuntungan berlebih (positif atau negatif) pada harga saham untuk melihat apakah insider mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi insider. Pertimbangkan situasi di mana insider melakukan hal ini. Dalam situasi ini, kita mengharapkan (a) keuntungan positif setelah pembelian, atau (b) keuntungan negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, yang menunjukkan keuntungan positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, yang menunjukkan keuntungan negatif setelah setiap transaksi penjualan.

Namun, hal ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam kenaikan non-siklus selama bertahun-tahun, maka kita perkirakan semua lahan pasca pembelian akan miring ke atas. Demikian pula, penurunan non-siklus selama bertahun-tahun akan mengakibatkan penurunan pasca-perdagangan. Tak satu pun dari grafik ini menunjukkan aktivitas insider trading.

Indikator terkuat adalah situasi di mana harga saham sangat bersiklus, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat memberi isyarat kepada insider yang mengatur waktu perdagangan demi keuntungan finansial mereka.

Riwayat Insider Trading

Tabel ini menunjukkan daftar lengkap perdagangan insider yang dilakukan oleh Gary L Crocker sebagaimana diungkapkan kepada Securities Exchange Commission (SEC).

Tanggal Berkas Tanggal Trans Formulir Kode Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Mengubah
Saham
Harga
Trans
Nilai
Tersisa
Nilai
2023-08-14 2023-08-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.000 133.105 1,53 12,43 24.865 1.654.841
2023-08-14 2023-08-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.000 133.105 1,53 12,52 25.039 1.666.421
2022-06-13 2022-06-09 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4.452 131.105 3,52 5,15 22.918 674.902
2022-06-09 2022-06-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 349 126.653 0,28 5,14 1.795 651.452
2022-06-09 2022-06-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 300 126.304 0,24 5,05 1.515 637.835
2022-05-26 2022-05-25 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 132 126.004 0,10 5,13 678 647.005
2022-05-26 2022-05-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.323 125.872 1,88 5,09 11.817 640.298
2022-05-23 2022-05-19 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 512 123.549 0,42 5,04 2.582 623.033
2022-05-19 2022-05-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 123.037 4,24 5,08 25.407 625.200
2022-05-19 2022-05-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 225 118.037 0,19 5,10 1.147 601.469
2022-05-16 2022-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3 117.812 0,00 4,90 15 577.279
2022-05-16 2022-05-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.471 117.809 2,14 5,04 12.456 593.863
2022-04-25 2022-04-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 115.338 4,53 6,00 30.001 692.051
2022-04-01 2022-03-31 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 300 110.338 0,27 6,18 1.853 681.525
2022-04-01 2022-03-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 161 110.038 0,15 6,20 998 682.236
2022-03-29 2022-03-28 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 109.877 4,77 6,16 30.822 677.315
2022-03-24 2022-03-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 400 104.877 0,38 6,11 2.446 641.197
2022-03-17 2022-03-15 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4.649 104.477 4,66 6,14 28.556 641.729
2022-03-15 2022-03-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 99.828 5,27 6,02 30.120 601.374
2022-03-15 2022-03-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 94.828 5,57 6,08 30.406 576.678
2022-02-23 2022-02-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.351 89.828 3,88 5,96 19.970 535.312
2022-02-18 2022-02-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 86.477 6,14 6,13 30.626 529.689
2022-02-18 2022-02-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7.945 81.477 10,80 6,20 49.231 504.872
2022-02-16 2022-02-15 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 123 73.532 0,17 6,20 763 455.898
2022-02-16 2022-02-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1.800 73.409 2,51 5,96 10.724 437.341
2022-01-31 2022-01-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 673 71.609 0,95 4,60 3.096 329.401
2022-01-27 2022-01-26 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.100 70.936 4,57 4,56 14.121 323.128
2022-01-25 2022-01-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7.105 67.836 11,70 4,33 30.741 293.506
2022-01-25 2022-01-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.000 60.731 3,41 4,65 9.310 282.691
2022-01-20 2022-01-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 58.731 9,31 4,54 22.690 266.515
2022-01-18 2022-01-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 53.731 10,26 4,51 22.554 242.364
2022-01-18 2022-01-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 48.731 11,43 4,42 22.120 215.591
2022-01-13 2022-01-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 43.731 12,91 4,33 21.658 189.425
2022-01-13 2022-01-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 38.731 14,82 4,03 20.140 156.012
2021-06-14 2021-06-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8.000 8.000
2021-04-14 2021-04-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 973 33.731 2,97 6,07 5.905 204.713
2021-04-12 2021-04-09 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1.200 32.758 3,80 6,10 7.320 199.824
2021-04-09 2021-04-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.127 31.558 7,23 6,19 13.166 195.344
2021-04-01 2021-03-31 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 500 29.431 1,73 6,19 3.094 182.148
2021-03-26 2021-03-25 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 200 28.931 0,70 6,13 1.226 177.347
2021-03-25 2021-03-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 28.731 21,07 6,34 31.690 182.097
2021-03-25 2021-03-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.627 23.731 18,04 6,47 23.455 153.461
2021-03-17 2021-03-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 20.104 33,10 6,79 33.956 136.530
2021-03-05 2021-02-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 15.104 49,49 7,20 36.004 108.762
2021-02-17 2021-02-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 10.104 97,96 7,47 37.342 75.461
2021-02-12 2021-02-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1.604 5.104 45,83 7,98 12.798 40.722
2021-02-12 2021-02-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.500 3.500 7,64 26.757 26.757
2020-08-03 2020-07-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8.000 8.000
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -6.228 0 -100,00 3,20 -19.942
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -17.250 0 -100,00 3,20 -55.234
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -52.068 0 -100,00 3,04 -158.386
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -86.549 0 -100,00 3,04 -263.273
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -8.428 0 -100,00 3,20 -26.986
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -5.986 0 -100,00 3,04 -18.209
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -17.000 0 -100,00 3,20 -54.434
2019-10-21 2019-10-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8.000 8.000
2018-06-15 2018-06-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8.000 8.000
2017-09-15 2017-09-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8.625 8.625
2016-06-16 2016-06-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 49.500 49.500
2015-05-18 2015-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 17.500 17.500
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -50.000 0 -100,00
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -35.000 0 -100,00
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 50.000 2.943.961 1,73 2,47 123.500 7.271.584
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 35.000 2.893.961 1,22 1,71 59.850 4.948.673
2014-11-14 2014-11-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 8.630 2.858.961 0,30 8,37 72.233 23.929.504
2014-11-14 2014-11-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.760 2.850.331 0,20 8,62 49.651 24.569.853
2014-06-24 2014-06-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 36.000 2.844.571 1,28 6,84 246.240 19.456.866
2014-05-22 2014-05-20 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4.000 2.808.571 0,14 6,69 26.760 18.789.340
2014-05-20 2014-05-19 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 6.000 2.804.571 0,21 6,71 40.260 18.818.671
2014-05-20 2014-05-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.400 2.798.571 0,12 6,63 22.542 18.554.526
2014-05-15 2014-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 37.834 37.834
2014-05-08 2014-05-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4.400 2.795.171 0,16 6,77 29.788 18.923.308
2014-05-07 2014-05-06 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7.500 2.790.771 0,27 6,85 51.375 19.116.781
2014-05-07 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 2.783.271 0,36 6,92 69.200 19.260.235
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -35.000 0 -100,00
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 35.000 2.773.271 1,28 1,25 43.750 3.466.589
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 2.738.271 0,37 6,69 66.900 18.319.033
2014-03-14 2014-03-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -50.000 0 -100,00
2014-03-14 2014-03-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 50.000 2.728.271 1,87 1,25 62.500 3.410.339
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69.000 2.678.271 2,64 3,74 257.998 10.014.323
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69.000 2.609.271 2,72 3,71 255.755 9.671.524
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69.000 2.540.271 2,79 3,71 255.783 9.416.785
2013-06-13 2013-06-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 37.834 37.834
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 15.015 2.471.271 0,61
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 15.015 2.456.256 0,62
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift -90.090 2.441.241 -3,56
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 39.000 2.531.331 1,56
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift -39.000 2.492.331 -1,54
2012-12-17 2012-12-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 36.500 2.531.331 1,46 6,77 247.214 17.144.705
2012-09-18 2012-09-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 25.800 2.494.831 1,04 8,34 215.172 20.806.891
2012-09-18 2012-09-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 39.000 2.469.031 1,60 8,32 324.437 20.539.622
2012-08-27 2012-08-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 31.600 31.600
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -450.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -22.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -22.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -23.300 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -23.300 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -28.332 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -28.332 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -21.429 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -21.429 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -79.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -79.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -35.714 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -184.975 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -300.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -30.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -15.863 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -313.266 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -41.900 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -46.676 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -463.654 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -59.863 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 450.000 2.430.031 22,73
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 22.000 1.980.031 1,12
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 22.000 1.980.031 1,12
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 23.300 1.958.031 1,20
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 23.300 1.958.031 1,20
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 28.332 1.934.731 1,49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 28.332 1.934.731 1,49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 21.429 1.906.399 1,14
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 21.429 1.906.399 1,14
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 79.000 1.884.970 4,37
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 79.000 1.884.970 4,37
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 35.714 1.631.909 2,24
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 184.975 1.596.195 13,11
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 300.000 1.411.220 27,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 30.000 1.111.220 2,77
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 15.863 1.081.220 1,49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 313.266 1.065.357 41,65
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 41.900 752.091 5,90
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 46.676 710.191 7,03
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 463.654 663.515 231,99
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 59.863 199.861 42,76
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 25.000 139.998 21,74 7,00 175.000 979.986
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 21.428 114.998 22,90 7,00 149.996 804.986
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 14.285 93.570 18,02 7,00 99.995 654.990
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 15.000 79.285 23,33 7,00 105.000 554.995
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 64.285 64.285 7,00 449.995 449.995
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)